.png)
GC Asia
Companies plot Star IPO comebacks
Shanghai Titan Scientific, Speechocean and Easton Biopharmaceuticals are all planning to make a second attempt at listing on Shanghai’s Star market.
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Or sign up for a trial to gain full access to the entire site for a limited period.
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
-
Latest news from GlobalCapital China
-
China policy round-up: China keeps count on symptom-free infections, Mofcom restricts export of uncertified medical supplies
03 Apr 2020 -
China market round-up: March Caixin manufacturing PMI back to expansion, Luckin Coffee admits to fake sales
03 Apr 2020 -
Xiaomi scores tight pricing in debut Panda bond
03 Apr 2020 -
BlackRock, Neuberger Berman start China fund race
02 Apr 2020 -
NDB finances emergency loan to China with Panda bond
02 Apr 2020
-
-
Latest news from GlobalCapital China
-
China policy round-up: China keeps count on symptom-free infections, Mofcom restricts export of uncertified medical supplies
03 Apr 2020 -
China market round-up: March Caixin manufacturing PMI back to expansion, Luckin Coffee admits to fake sales
03 Apr 2020 -
Xiaomi scores tight pricing in debut Panda bond
03 Apr 2020 -
BlackRock, Neuberger Berman start China fund race
02 Apr 2020 -
NDB finances emergency loan to China with Panda bond
02 Apr 2020
-
Further Reading
-
Regulation & Policy
China policy round-up: China keeps count on symptom-free infections, Mofcom restricts export of uncertified medical supplies
-
Asia - Market News/Regulation
China market round-up: March Caixin manufacturing PMI back to expansion, Luckin Coffee admits to fake sales
-
Bonds
Xiaomi scores tight pricing in debut Panda bond
-
People & Markets
BlackRock, Neuberger Berman start China fund race
